{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:54:55Z","timestamp":1778745295145,"version":"3.51.4"},"reference-count":46,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1620\/tjem.235.117","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T17:02:29Z","timestamp":1423846949000},"page":"117-125","source":"Crossref","is-referenced-by-count":10,"title":["Efficient Screening Strategy for Lynch Syndrome in Japanese Endometrial Cancer"],"prefix":"10.1620","volume":"235","author":[{"given":"Tae","family":"Sugawara","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kito","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Akita University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L.A., de la Chapelle, A., Peltom\u00e4ki, P., Mecklin, J.P. &amp; J\u00e4rvinen. H.J. (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. <i>Int. J. Cancer<\/i>, 81, 214-218.","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Backes, F.J., Leon, M.E., Ivanov, I., Suarez, A., Frankel, W.L., Hampel, H., Fowler, J.M., Copeland, L.J., O\u2019Malley, D.M. &amp; Cohn, D.E. (2009) Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. <i>Gynecol. Oncol.<\/i>, 114, 486-490.","DOI":"10.1016\/j.ygyno.2009.05.026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Backes, F.J., Mitchell, E., Hampel, H. &amp; Cohn, D.E. (2011) Endometrial cancer patients and compliance with genetic counseling: room for improvement. <i>Gynecol. Oncol.<\/i>, 123, 532-536.","DOI":"10.1016\/j.ygyno.2011.09.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Batte, B.A., Bruegl, A.S., Daniels, M.S., Ring, K.L., Dempsey, K.M., Djordjevic, B., Luthra, R., Fellman, B.M., Lu, K.H. &amp; Broaddus, R.R. (2014) Consequences of universal MSI\/IHC in screening endometrial cancer patients for Lynch syndrome. <i>Gynecol. Oncol.<\/i>, 134, 319-325.","DOI":"10.1016\/j.ygyno.2014.06.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Benatti, P., Sassatelli, R., Roncucci, L., Pedroni, M., Fante, R., Di Gregorio, C., Losi, L., Gelmini, R. &amp; Ponz de Leon, M. (1993) Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with \u201csuspected HNPCC.\u201d A population-based study in northern Italy. Colorectal Cancer Study Group. <i>Int. J. Cancer<\/i>, 54, 371-377.","DOI":"10.1002\/ijc.2910540304"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Black, D., Soslow, R.A., Levine, D.A., Tornos, C., Chen, S.C., Hummer, A.J., Bogomolniy, F., Olvera, N., Barakat, R.R. &amp; Boyd, J. (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. <i>J. Clin. Oncol.<\/i>, 24, 1745-1753.","DOI":"10.1200\/JCO.2005.04.1574"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Boilesen, A.E., Bisgaard, M.L. &amp; Bernstein, I. (2008) Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families. <i>Acta Obstet. Gynecol. Scand.<\/i>, 87, 1129-1135.","DOI":"10.1080\/00016340802443806"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Bruegl, A.S., Djordjevic, B., Batte, B., Daniels, M., Fellman, B., Urbauer, D., Luthra, R., Sun, C., Lu, K.H. &amp; Broaddus, R.R. (2014a) Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. <i>Cancer Prev. Res.<\/i>, 7, 686-697.","DOI":"10.1158\/1940-6207.CAPR-13-0359"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Bruegl, A.S., Djordjevic, B., Urbauer, D.L., Westin, S.N., Soliman, P.T., Lu, K.H., Luthra, R. &amp; Broaddus, R.R. (2014b) Utility of MLH1 methylation analysis in the clinical evaluation of Lynch syndrome in women with endometrial cancer. <i>Curr. Pham. Des.<\/i>, 20, 1655-1663.","DOI":"10.2174\/13816128113199990538"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Buchanan, D.D., Tan, Y.Y., Walsh, M.D., Clendenning, M., Metcalf, A.M., Ferguson, K., Arnold, S.T., Thompson, B.A., Lose, F.A., Parsons, M.T., Walters, R.J., Pearson, S.A., Cummings, M., Oehler, M.K., Blomfield, P.B., et al. (2014) Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. <i>J. Clin. Oncol.<\/i>, 32, 90-100.","DOI":"10.1200\/JCO.2013.51.2129"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Esteller, M., Levine, R., Baylin, S.B., Ellenson, L.H. &amp; Herman, J.G. (1998) MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. <i>Oncogene<\/i>, 17, 2413-2417.","DOI":"10.1038\/sj.onc.1202178"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Evaluation of Geonomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. <i>Genet. Med.<\/i>, 11, 35-41.","DOI":"10.1097\/GIM.0b013e31818fa2ff"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ferguson, S.E., Aronson, M., Pollett, A., Eiriksson, L.R., Oza, A.M., Gallinger, S., Lerner-Ellis, J., Alvandi, Z., Bernardini, M.Q., MacKay, H.J., Mojtahedi, G., Tone, A.A., Massey, C. &amp; Clarke, B.A. (2014) Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. <i>Cancer<\/i>, 120, 3932-3939.","DOI":"10.1002\/cncr.28933"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Garg, K. &amp; Soslow, R.A. (2009) Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. <i>J. Clin. Pathol.<\/i>, 62, 679-684.","DOI":"10.1136\/jcp.2009.064949"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Gausachs, M., Mur, P., Corral, J., Pineda, M., Gonz\u00e1lez, S., Benito, L., Men\u00e9ndez, M., Espin\u00e0s, J.A., Brunet, J., Iniesta, M.D., Gruber, S.B., L\u00e1zaro, C., Blanco, I. &amp; Capell\u00e1, G. (2012) MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. <i>Eur. J. Hum. Genet.<\/i>, 20, 762-768.","DOI":"10.1038\/ejhg.2011.277"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hampel, H., Frankel, W., Panescu, J., Lockman, J., Sotamaa, K., Fix, D., Comeras, I., La Jeunesse, J., Nakagawa, H., Westman, J.A., Prior, T.W., Clendenning, M., Penzone, P., Lombardi, J., Dunn, P., et al. (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. <i>Cancer Res.<\/i>, 66, 7810-7817.","DOI":"10.1158\/0008-5472.CAN-06-1114"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hendriks, Y.M., Wagner, A., Morreau, H., Menko, F., Stormorken, A., Quehenberger, F., Sandkuijl, L., M\u00f8ller, P., Genuardi, M., Van Houwelingen, H., Tops, C., Van Puijenbroek, M., Verkuijlen, P., Kenter, G., Van Mil, A., et al. (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. <i>Gastroenterology<\/i>, 127, 17-25.","DOI":"10.1053\/j.gastro.2004.03.068"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hirai, Y., Banno, K., Suzuki, M., Ichikawa, Y., Udagawa, Y., Sugano, K. &amp; Miki, Y. (2008) Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. <i>Cancer Sci.<\/i>, 99, 1715-1719.","DOI":"10.1111\/j.1349-7006.2008.00886.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kwon, J.S., Scott, J.L., Gilks, C.B., Daniels, M.S., Sun, C.C. &amp; Lu, K.H. (2011) Testing women with endometrial cancer to detect Lynch syndrome. <i>J. Clin. Oncol.<\/i>, 29, 2247-2252.","DOI":"10.1200\/JCO.2010.32.9979"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lancaster, J.M., Powell, C.B., Kauff, N.D., Cass, I., Chen, L.M., Lu, K.H., Mutch, D.G., Berchuck, A., Karlan, B.Y. &amp; Herzog, T.J. (2007) Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. <i>Gynecol. Oncol.<\/i>, 107, 159-162.","DOI":"10.1016\/j.ygyno.2007.09.031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Leenen, C.H., van Lier, M.G., van Doorn, H.C., van Leerdam, M.E., Kooi, S.G., de Waard, J., Hoedemaeker, R.F., van den Ouweland, A.M., Hulspas, S.M., Dubbink, H.J., Kuipers, E.J., Wagner, A., Dinjens, W.N. &amp; Steyerberg, E.W. (2012) Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer \u2264 70 years. <i>Gynecol. Oncol.<\/i>, 125, 414-420.","DOI":"10.1016\/j.ygyno.2012.01.049"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lindor, N.M., Petersen, G.M., Hadley, D.W., Kinney, A.Y., Miesfeldt, S., Lu, K.H., Lynch, P., Burke, W. &amp; Press, N. (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. <i>JAMA<\/i>, 296, 1507-1517.","DOI":"10.1001\/jama.296.12.1507"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lipton, L.R., Johnson, V., Cummings, C., Fisher, S., Risby, P., Eftekhar Sadat, A.T., Cranston, T., Izatt, L., Sasieni, P., Hodgson, S.V., Thomas, H.J. &amp; Tomlinson, I.P. (2004) Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. <i>J. Clin. Oncol.<\/i>, 22, 4934-4943.","DOI":"10.1200\/JCO.2004.11.084"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Lu, K.H. &amp; Broaddus, R.R. (2005) Gynecologic cancers in Lynch syndrome\/HNPCC. <i>Fam. Cancer<\/i>, 4, 249-254.","DOI":"10.1007\/s10689-005-1838-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Lu, K.H., Dinh, M., Kohlmann, W., Watson, P., Green, J., Syngal, S., Bandipalliam, P., Chen, L.M., Allen, B., Conrad, P., Terdiman, J., Sun, C., Daniels, M., Burke, T., Gershenson, D.M., et al. (2005) Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome. <i>Obstet. Gynecol.<\/i>, 105, 569-574.","DOI":"10.1097\/01.AOG.0000154885.44002.ae"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Lu, K.H., Schorge, J.O., Rodabaugh, K.J., Daniels, M.S., Sun, C.C., Soliman, P.T., White, K.G., Luthra, R., Gershenson, D.M. &amp; Broaddus, R.R. (2007) Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. <i>J. Clin. Oncol.<\/i>, 25, 5158-5164.","DOI":"10.1200\/JCO.2007.10.8597"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Matthews, K.S., Estes, J.M., Conner, M.G., Manne, U., Whitworth, J.M., Huh, W.K., Alvarez, R.D., Straughn, J.M. Jr., Barnes, M.N. &amp; Rocconi, R.P. (2008) Lynch syndrome in women less than 50 years of age with endometrial cancer. <i>Obstet. Gynecol.<\/i>, 111, 1161-1166.","DOI":"10.1097\/AOG.0b013e31817051d9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Modica, I., Soslow, R.A., Black, D., Tornos, C., Kauff, N. &amp; Shia, J. (2007) Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. <i>Am. J. Surg. Pathol.<\/i>, 31, 744-751.","DOI":"10.1097\/01.pas.0000213428.61374.06"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Moline, J., Mahdi, H., Yang, B., Biscotti, C., Roma, A.A., Heald, B., Rose, P.G., Michener, C. &amp; Eng, C. (2013) Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. <i>Gynecol. Oncol.<\/i>, 130, 121-126.","DOI":"10.1016\/j.ygyno.2013.04.022"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Park, J.G., Park, Y.J., Wijnen, J.T. &amp; Vasen, H.F. (1999) Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. <i>Int. J. Cancer<\/i>, 82, 516-519.","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<516::AID-IJC8>3.0.CO;2-U"},{"key":"31","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Carbonell, L., Alenda, C., Pay\u00e1, A., Castillejo, A., Barber\u00e1, V.M., Guill\u00e9n, C., Rojas, E., Acame, N., Guti\u00e9rrez-Avi\u00f1\u00f3, F.J., Castells, A., Llor, X., Andreu, M., Soto, J.L. &amp; Jover, R. (2010) Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. <i>J. Mol. Diagn.<\/i>, 12, 498-504.","DOI":"10.2353\/jmoldx.2010.090212"},{"key":"32","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Carbonell, L., Ruiz-Ponte, C., Guarinos, C., Alenda, C., Pay\u00e1, A., Brea, A., Egoavil, C.M., Castillejo, A., Barber\u00e1, V.M., Bessa, X., Xicola, R.M., Rodr\u00edguez-Soler, M., S\u00e1nchez-Fort\u00fan, C., Acame, N., Castellv\u00ed-Bel, S., et al. (2012) Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. <i>Gut<\/i>, 61, 865-872.","DOI":"10.1136\/gutjnl-2011-300041"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ol, V., Castells, A., Andreu, M., Castellv\u00ed-Bel, S., Alenda, C., Llor, X., Xicola, RM., Rodr\u00edguez-Moranta, F., Pay\u00e1, A., Jover, R. &amp; Bessa, X. (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. <i>JAMA<\/i>, 293, 1986-1994.","DOI":"10.1001\/jama.293.16.1986"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Resnick, K.E., Hampel, H., Fishel, R. &amp; Cohn, D.E. (2009) Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. <i>Gynecol. Oncol.<\/i>, 114, 128-134.","DOI":"10.1016\/j.ygyno.2009.03.003"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Soler, M., P\u00e9rez-Carbonell, L., Guarinos, C., Zapater, P., Castillejo, A., Barber\u00e1, V.M., Ju\u00e1rez, M., Bessa, X., Xicola, R.M., Clofent, J., Bujanda, L., Balaguer, F., Re\u00f1\u00e9, J.M., de-Castro, L., Mar\u00edn-Gabriel, J.C., et al. (2013) Risk of cancer in cases of suspected Lynch syndrome without germline mutation. <i>Gastroenterology<\/i>, 144, 926-932.","DOI":"10.1053\/j.gastro.2013.01.044"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Ryan, P., Mulligan, A.M., Aronson, M., Ferguson, S.E., Bapat, B., Semotiuk, K., Holter, S., Kwon, J., Kalloger, S.E., Gilks, C.B., Gallinger, S., Pollett, A. &amp; Clarke, B.A. (2012) Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. <i>Cancer<\/i>, 118, 681-688.","DOI":"10.1002\/cncr.26323"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J.D., Lindblom, A., Lagerstedt, K., Thibodeau, S.N., Lindor, N.M., Young, J., Winship, I., Dowty, J.G., White, D.M., Hopper, J.L., et al. (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. <i>Gastroenterology<\/i>, 135, 419-428.","DOI":"10.1053\/j.gastro.2008.04.026"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Stoffel, E., Mukherjee, B., Raymond, V.M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S. &amp; Gruber, S.B. (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. <i>Gastroenterology<\/i>, 137, 1621-1627.","DOI":"10.1053\/j.gastro.2009.07.039"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Syngal, S., Fox, E.A., Eng, C., Kolodner, R.D. &amp; Garber, J.E. (2000) Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. <i>J. Med. Genet.<\/i>, 37, 641-645.","DOI":"10.1136\/jmg.37.9.641"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Tutlewska, K., Lubinski, J. &amp; Kurzawski, G. (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review. <i>Hered. Cancer Clin. Pract.<\/i>, 11, 9.","DOI":"10.1186\/1897-4287-11-9"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Umar, A., Boland, C.R., Terdiman, J.P., Syngal, S., de la Chapelle, A., R\u00fcschoff, J., Fishel, R., Lindor, N.M., Burgart, L.J., Hamelin, R., Hamilton, S.R., Hiatt, R.A., Jass, J., Lindblom, A., Lynch, H.T., et al. (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. <i>J. Natl. Cancer Inst.<\/i>, 96, 261-268.","DOI":"10.1093\/jnci\/djh034"},{"key":"42","doi-asserted-by":"crossref","unstructured":"van Lier, M.G., Wagner, A., van Leerdam, M.E., Biermann, K., Kuipers, E.J., Steyerberg, E.W., Dubbink, H.J. &amp; Dinjens, W.N. (2010) A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. <i>J. Cell. Mol. Med.<\/i>, 14, 181-197.","DOI":"10.1111\/j.1582-4934.2009.00977.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Vasen, H.F., Blanco, I., Aktan-Collan, K., Gopie, J.P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., Colas, C., Engel, C., Frayling, I.M., Genuardi, M., Heinimann, K., et al. (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. <i>Gut<\/i>, 62, 812-823.","DOI":"10.1136\/gutjnl-2012-304356"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Vasen, H.F., M\u00f6slein, G., Alonso, A., Bernstein, I., Bertario, L., Blanco, I., Burn, J., Capella, G., Engel, C., Frayling, I., Friedl, W., Hes, F.J., Hodgson, S., Mecklin, J.P., M\u00f8ller, P., et al. (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). <i>J. Med. Genet.<\/i>, 44, 353-362.","DOI":"10.1136\/jmg.2007.048991"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Vasen, H.F., Watson, P., Mecklin, J.P. &amp; Lynch, H.T. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. <i>Gastroenterology<\/i>, 116, 1453-1456.","DOI":"10.1016\/S0016-5085(99)70510-X"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Win, A.K., Lindor, N.M., Winship, I., Tucker, K.M., Buchanan, D.D., Young, J.P., Rosty, C., Leggett, B., Giles, G.G., Goldblatt, J., Macrae, F.A., Parry, S., Kalady, M.F., Baron, J.A., Ahnen, D.J., et al. (2013) Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. <i>J. Natl. Cancer Inst.<\/i>, 105, 274-279.","DOI":"10.1093\/jnci\/djs525"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/235\/2\/235_117\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T01:31:07Z","timestamp":1498181467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/235\/2\/235_117\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.235.117","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}